THE PRINCIPAL TUMOR-NECROSIS-FACTOR RECEPTOR IN MONOCYTE CYTOTOXICITY IS ON THE EFFECTOR CELL, NOT ON THE TARGET-CELL

被引:19
|
作者
PECK, R
BROCKHAUS, M
FREY, JR
机构
[1] F. Hoffmann-LaRoche Ltd.
关键词
D O I
10.1016/0008-8749(91)90030-F
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Several tumor target cell lines, prototypically K562 cells, are resistant to lysis by recombinant tumor necrosis factor (TNFα) but are killed by monocytes expressing membrane-associated TNF, suggesting that membrane TNF could account for monocyte-mediated cytotoxicity. Formaldehydefixed monocytes or extracted monocyte membrane fragments are cytotoxic to K562 target cells. Treatment of monocytes with interferon-γ (IFN-γ) increases cytotoxicity by live and fixed cells or by extracted monocyte membranes. Both TNF and TNF receptors are detectable on monocyte membranes by FACS analysis, and the levels of each are modulated by treatment with IFN-γ. Cytotoxicity can be inhibited by either anti-TNF or anti-TNF receptor antibodies. Incubation of effector cells with exogenous soluble TNF prior to fixation or membrane preparation increases their cytotoxicity. In contrast, incubation of the target cells with exogenous TNF neither increases nor decreases killing by effector cell membrane fragments or intact effector cells. The data suggest that the TNF receptors on the effector cell, but not on the target cell, play a crucial role in TNF-mediated cytotoxicity. © 1991.
引用
收藏
页码:308 / 318
页数:11
相关论文
共 50 条
  • [41] TUMOR-NECROSIS-FACTOR RECEPTOR EXPRESSION ON HUMAN PROSTATE-CANCER CELL-LINES
    NAKAJIMA, Y
    MALLOUH, C
    TAZAKI, H
    FERRERI, NR
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A218 - A218
  • [42] THE INHIBITORY EFFECTS OF ALLOPURINOL ON THE PRODUCTION AND CYTOTOXICITY OF TUMOR-NECROSIS-FACTOR
    OLAH, T
    REGELY, K
    MANDI, Y
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 350 (01) : 96 - 99
  • [43] PROTECTION FROM TUMOR-NECROSIS-FACTOR CYTOTOXICITY BY PROTEASE INHIBITORS
    RUGGIERO, V
    JOHNSON, SE
    BAGLIONI, C
    CELLULAR IMMUNOLOGY, 1987, 107 (02) : 317 - 325
  • [44] TUMOR-NECROSIS-FACTOR AS A POTENT EFFECTOR MOLECULE FOR TUMOR-CELL KILLING BY ACTIVATED RAT PERITONEAL-MACROPHAGES INVITRO
    KUSENDA, J
    KALAFUT, F
    KLOBUSICKA, M
    NOVOTNA, L
    NEOPLASMA, 1992, 39 (01) : 23 - 28
  • [45] EARLY EVENTS IN TUMOR-NECROSIS-FACTOR (TNF)-MEDIATED CYTOTOXICITY
    GRAVES, S
    BONAVIDA, B
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 765 - 765
  • [46] TUMOR-NECROSIS-FACTOR - A PLEIOTROPIC CYTOKINE AND THERAPEUTIC TARGET
    TRACEY, KJ
    CERAMI, A
    ANNUAL REVIEW OF MEDICINE, 1994, 45 : 491 - 503
  • [47] SPONTANEOUS PRODUCTION OF A TUMOR-NECROSIS-FACTOR BY A NOVEL TUMOR-CELL LINE
    WALLIS, R
    PANUSKA, J
    GRAHAM, R
    ELLNER, J
    CLINICAL RESEARCH, 1987, 35 (03): : A611 - A611
  • [48] TUMOR-NECROSIS-FACTOR PRODUCTION IN HUMAN EPITHELIAL TUMOR-CELL LINES
    SPRIGGS, DR
    IMAMURA, K
    RODRIGUEZ, C
    SARIBAN, E
    HORIGUCHI, J
    SHERMAN, ML
    KUFE, DW
    IMMUNOBIOLOGY, 1987, 175 (1-2) : 35 - 36
  • [49] SPIN TRAP PROTECTION FROM TUMOR-NECROSIS-FACTOR CYTOTOXICITY
    POGREBNIAK, H
    MATTHEWS, W
    MITCHELL, J
    RUSSO, A
    SAMUNI, A
    PASS, H
    JOURNAL OF SURGICAL RESEARCH, 1991, 50 (05) : 469 - 474
  • [50] THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR
    GRELL, M
    DOUNI, E
    WAJANT, H
    LOHDEN, M
    CLAUSS, M
    MAXEINER, B
    GEORGOPOULOS, S
    LESSLAUER, W
    KOLLIAS, G
    PFIZENMAIER, K
    SCHEURICH, P
    CELL, 1995, 83 (05) : 793 - 802